Table 2 Relationship between SEMA3D expression and clinicopathologic characteristic of CRC patients
Characteristics | Number | Expression of SEMA3D | P value | |
|---|---|---|---|---|
Low | High | |||
Age (years) | 0.826 | |||
≤60 | 75 | 39 (52.0%) | 36 (48.0%) | |
>60 | 140 | 75 (53.6%) | 65 (46.4%) | |
Gender | 0.767 | |||
Male | 134 | 70 (52.2%) | 4 (47.8%) | |
Female | 81 | 44 (54.3%) | 37 (45.7%) | |
Site | 0.399 | |||
Colon | 113 | 63 (55.8%) | 50 (44.2%) | |
Rectum | 102 | 51 (50%) | 51 (50%) | |
Size (cm) | 0.505 | |||
≤5 | 162 | 88 (54.3%) | 74 (45.7%) | |
>5 | 53 | 26 (49.1%) | 27 (50.9%) | |
General type | 0.849 | |||
Ulcerated | 93 | 50 (53.8%) | 43 (46.2%) | |
Others | 122 | 64 (52.5%) | 58 (47.5%) | |
Differentiation | 0.062 | |||
Well/moderate | 169 | 84 (49.7%) | 85 (50.3%) | |
Poor/undifferentiated | 46 | 30 (65.2%) | 16 (34.8%) | |
Lymph node metastasis | 0.004 | |||
Negative | 129 | 58 (45.0%) | 71 (55.0%) | |
Positive | 86 | 56 (65.1%) | 30 (34.9%) | |